1) Clinically significant adverse reactions: Since insanity, epilepsy-like seizure and spasms (0.1 to <5%) may appear, patients should be thoroughly monitored. Administration should be discontinued and suitable measures should be taken if these symptoms appear.
2) Other adverse reactions: See Table 4.
Click on icon to see table/diagram/image
View ADR Reporting Link
Sign Out